InvestorsHub Logo
icon url

Gator328

09/29/23 10:12 PM

#433553 RE: falconer66a #433552

We won’t have a prevention trial for years. I’d imagine they’d need more accurate predictors of CNS and then the trial itself would probably be 5-10 years long. This company will be sold before that happens (or as some here think, out of business)
icon url

nidan7500

09/30/23 9:25 AM

#433573 RE: falconer66a #433552

falconer-Plex -others



Even more; much more.
falconer-"Going to be far more than just Rett, Alzheimer's,"--Epilepsy and ALS are 2 that quickly come to mind---some day !!!!!!!!


Yes, Totally , " Anavex's ability to favorably modulate the diverse and profound activities of the sigma-1 receptor protein is going to be manifested in the successful treatment of a diversity of CNS diseases, as mentioned.

But what will be the implications and results when it is discovered (as Anavex already knows from tests in both lab murines and Caenorhabditis elegans roundworms) that blarcamesine and Anavex 3-71 not only treat existing CNS diseases but actually prevent their onset; the prophylaxis factor? The Anavex molecules will prevent various diseases and delay or slow aging processes. Really big.



WOW, that sure is an awful lot of dots. But this new knowledge would be consistent w/"systems thinking expectation". Stand by to address the lack of humility as the W/S thieves ie BP are made aware of what ..."they don't know, they don't know". and what it has cost us all.

IMO, AI will be helpful in peeling the newly visible , "What If", onions which are certain to follow the science of newly discovered causal CNS links. It is all only a matter of time now.